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and study design for the Stand Up Victoria
cluster randomized trial
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Background: Excessive time spent in sedentary behaviours (sitting or lying with low energy expenditure) is
associated with an increased risk for type 2 diabetes, cardiovascular disease and some cancers. Desk-based office
workers typically accumulate high amounts of daily sitting time, often in prolonged unbroken bouts. The Stand Up
Victoria study aims to determine whether a 3-month multi-component intervention in the office setting reduces
workplace sitting, particularly prolonged, unbroken sitting time, and results in improvements in cardio-metabolic
biomarkers and work-related outcomes, compared to usual practice.
Methods/Design: A two-arm cluster-randomized controlled trial (RCT), with worksites as the unit of randomization,
will be conducted in 16 worksites located in Victoria, Australia. Work units from one organisation (Department of
Human Services, Australian Government) will be allocated to either the multi-component intervention (organisational,
environmental [height-adjustable workstations], and individual behavioural strategies) or to a usual practice control
group. The recruitment target is 160 participants (office-based workers aged 18–65 years and working at least 0.6 full
time equivalent) per arm. At each assessment (0- [baseline], 3- [post intervention], and 12-months [follow-up]), objective
measurement via the activPAL3 activity monitor will be used to assess workplace: sitting time (primary outcome);
prolonged sitting time (sitting time accrued in bouts of ≥30 minutes); standing time; sit-to-stand transitions; and,
moving time. Additional outcomes assessed will include: non-workplace activity; cardio-metabolic biomarkers and
health indicators (including fasting glucose, lipids and insulin; anthropometric measures; blood pressure; and,
musculoskeletal symptoms); and, work-related outcomes (presenteeism, absenteeism, productivity, work performance).
Incremental cost-effectiveness and identification of both workplace and individual-level mediators and moderators of
change will also be evaluated.
Discussion: Stand Up Victoria will be the first cluster-RCT to evaluate the effectiveness of a multi-component intervention
aimed at reducing prolonged workplace sitting in office workers. Strengths include the objective measurement of activity
and assessment of the intervention on markers of cardio-metabolic health. Health- and work-related benefits, as well as
the cost-effectiveness of the intervention, will help to inform future occupational practice.
Trial registration: ACTRN1211000742976
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Current public health guidelines recommend engaging
in at least 30 minutes of moderate- to vigorous-intensity
physical activity (MVPA) on most days, in order to pre-
vent chronic diseases such as type 2 diabetes and cardio-
vascular disease [1,2]. However, most adults spend much
of their time in environments that not only limit their
physical activity, but also require them to sit for pro-
longed periods of time. Increasingly, evidence suggests
that sedentary behaviour may adversely affect health in-
dependent of leisure-time MVPA participation [3,4].
Over the past decade, observational studies have demon-
strated that total time spent sedentary, and the manner
in which sedentary time is accumulated, is detrimentally
associated with several health outcomes including ele-
vated markers of cardio-metabolic risk, type 2 diabetes,
obesity, cardiovascular disease, breast and colon cancer
and premature mortality [5,6]. These adverse health rela-
tionships, coupled with the high proportion of the wak-
ing day spent in this behaviour [7], have prompted calls
for interventions to specifically target a reduction in sit-
ting time [8,9], with a particular focus on high-risk set-
tings such as the office workplace [10-12].
The potential hazards of prolonged sitting in the work-
place were first highlighted as early as the 17th century
when the distinguished occupational physician Ramaz-
zini [13] reported that relationships between sedentary
behaviour and deleterious health consequences were evi-
dent in workers whose occupations required them to sit
for long hours. In the 1950s, Morris and colleagues [14]
reported that workers in occupations requiring primarily
sitting (London bus drivers and mail sorters) had a
higher incidence of coronary heart disease than did
workers who were required to stand and ambulate (bus
conductors and postal delivery workers). In recent de-
cades, significant alterations in workplace environments
and work practices have occurred, largely driven by
technological innovations, such as computers and other
labour-saving devices [15]. This was recently highlighted
in an analysis of the trends in occupational physical ac-
tivity during the past 50 years in the USA, showing that
there has been a progressive shift away from occupations
that require moderate-intensity physical activity to occu-
pations that largely require sitting [16].
Recent observational studies using objective measures
of physical activity and sedentary time have provided
new evidence on the extent of time spent sitting in the
modern workplace – particularly among office-based
workers [11,17-20]. In an Australian sample of 193 em-
ployees working in offices, call centres and customer ser-
vice employees, Thorp et al. reported that sedentary
time (derived from hip-worn accelerometers) comprised
more than three-quarters (77%) of total work hours [11],
a finding consistent with those observed in Scottish [19]and Swedish workers [21]. In those studies that have
specifically assessed the manner in which the sedentary
time was accumulated, a considerable amount of work-
place sedentary time (22-52%) was accrued in prolonged
unbroken bouts (≥ 30 minutes) [19,20,22]. Such extended
periods of uninterrupted sitting may have important
health implications [23]. Current recommendations, based
largely on expert consensus and emanating from musculo-
skeletal medicine [19,24-26], suggest postural transitions
at least every 20–30 minutes. Furthermore, recent ex-
perimental evidence has suggested that restricting sitting
time durations to those advocated in these recommenda-
tions may also provide metabolic benefits, as demon-
strated by the acute lowering of post-prandial glucose
and insulin with sitting interrupted every 20 minutes
with brief (two minute) bouts of activity compared to
uninterrupted sitting [27].
Historically, interventions that have specifically ad-
dressed workplace sitting have emanated primarily from
an ergonomics perspective, with an emphasis on redu-
cing musculoskeletal complaints, rather than reducing
sitting time per se [12,28,29]. The associated interven-
tion strategies have included: increasing the number of
breaks from sitting time [30-33]; promoting regular pos-
tural changes [29,34]; and, ergonomic changes to the in-
dividual workspace, including the use of sit-stand
workstations [35-37]. Collectively, these studies have
demonstrated that frequent changes in posture can have
a beneficial impact on musculoskeletal health, either a
beneficial or neutral effect on productivity, and were
rated as preferable compared to either just sitting or
standing [12].
More recently, workplace interventions with a specific
public health focus have been developed. Here, the lar-
gest reductions in workplace sitting time in the studies
to date have been observed when the intervention
targeted an individual-level environmental modification
(e.g. a sit-stand workstation) [17,38-40]. Individual-based
counselling [18] and computer prompt software [22]
have also been modestly effective. Small improvements
in blood lipids, reduced upper back and neck pain and
improved mood states following intervention have been
noted [17,39]. However, the methodological limitations
of these studies - use of non-randomised study designs,
small sample sizes, short follow-up periods and/or poor
control for confounding - have precluded definitive con-
clusions on the possible impact of such interventions on
health outcomes or health risk indicators. Larger cluster-
randomised trials in non-university staff samples are
urgently needed as these: can better control for con-
founding; improve generalizability; have the capacity to
explore effect modification; and, provide more precise
estimates of potential effects on anthropometric, bio-
marker, health, and work-related outcomes. The present
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these significant gaps in evidence.
Rationale for the Stand Up Victoria intervention
Modern workplace health intervention frameworks draw
principally from two disciplines: occupational health &
safety (OH&S) and workplace health promotion. OH&S
prioritises intervention at the source of the hazard (pri-
mary prevention), followed by control of the hazard at
the level of the worker (secondary prevention, such as
through the use of personal protective equipment), and
finally the management of work-related illness or injury
if it occurs (tertiary intervention, including treatment,
rehabilitation and return to work) [41,42]. Workplace
health promotion has traditionally focussed on personal
health behaviours that influence chronic disease risk,
such as smoking and leisure-time physical activity. More
recently, it has been acknowledged that working condi-
tions can also contribute to chronic disease risk and
should therefore be targeted alongside health behaviours
[41,43,44]. There has been a recent convergence of these
two perspectives, as exemplified in the 2010 WHO
‘healthy workplace’ model [45]. This framework empha-
sises that best practice intervention should involve an in-
tegrated approach, involving individual, environmental,
and organisational-level change components [43,45,46].
The Stand Up Victoria intervention follows these prin-
ciples of an integrated approach: a method that is con-
sistent with ecological frameworks for sedentary
behaviour that emphasise the need to consider multiple
levels of influence on the behaviour [47].
Here we provide a detailed overview of the Stand Up
Victoria study including its aims, intervention methods,
and evaluation protocol.
Methods/Design
Aims
The primary aim of the Stand Up Victoria study is to de-
termine whether a 3-month multi-component workplace
intervention, incorporating organisational-, environmental-
, and individual-level strategies, results in reductions in
workplace sitting time (primary outcome) in office wor-
kers. Secondary aims are to: determine the impact of the
intervention on other activity outcomes (prolonged sitting,
standing and moving at work; sitting, standing and moving
across the whole day) and on health- and work-related out-
comes; identify the factors that mediate and moderate
intervention impacts; assess intervention cost-effectiveness;
and, evaluate the extent to which changes are maintained
9-months post intervention.
Study design
Stand Up Victoria is a two-arm cluster-randomised con-
trolled trial in office workers with worksites being theunit of randomisation. The 12-month study protocol in-
cludes three assessment time-points: baseline, 3-months
(end of intervention) and 12-months (maintenance). A
study overview showing the major components and
time-points is given in Figure 1. Stand Up Victoria is
funded by a National Health and Medical Research
Council (NHMRC) Project Grant (#1002706) and the
Victorian Health Promotion Foundation (VicHealth).
Ethics approval was granted by Alfred Health Human
Ethics Committee (Melbourne, Australia). Contract and
tender approval with the partner organisation was pro-
vided by senior management. The study will be con-
ducted in accordance with the CONSORT guidelines
(http://www.consort-statement.org/).
Study population
Participants will be office workers, recruited from 16 dif-
ferent study sites from the one organisation. The aim is
to recruit 160 participants per condition (see sample size
calculations). Participant eligibility will be based on
working at least 0.6 full time equivalent hours (FTE),
aged 18–65 years, speaking English, and having desig-
nated access to a telephone, internet and desk within the
workplace. Participants will be excluded from the study
if they are pregnant, non-ambulatory, have a pre-existing
musculoskeletal complaint, and/or have a planned ab-
sence from work for >2 weeks or a planned relocation to
another workplace during the 3-month intervention
period.
Recruitment
Recruitment of organisation
A multi-site organisation has been recruited via a tender
process to be a partner in this project through provision
of its’ workplaces and employees as participants. The
selected organisation, Department of Human Services
(DHS), is the Australian government department respon-
sible for the delivery of social and health-related payments
and services including employment benefits, student bene-
fits, child support payments and Medicare benefits. In
2011–2012, DHS employed 36, 977 staff across 523 service
centres Australia-wide (www.humanservices.gov.au).
Recruitment of study sites
DHS workplaces (i.e. study sites; defined as geographic-
ally separate DHS buildings) within the state of Victoria
that are not currently delivering a physical activity pro-
gram for their staff will be eligible to participate. Sites
will be identified by a DHS employee designated as the
research liaison person. Within each site, a team (i.e. a
distinct working group within the site that has a line
manager and regular group meetings and interactions)
will be identified. If the team size falls below a threshold
of <10 employees, a second (small: <10 employees) team
Upper Management Consultation & Consent
Representatives consultation workshop
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Individual Recruitment and Consent
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screening for eligibility; written  informed consent
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Figure 1 Study overview.
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participate. Written consent will be obtained from the
appropriate divisional manager(s) of each team partici-
pating at eligible sites. Information sessions will be con-
ducted by the research team for the appropriate managers
outlining the study requirements and expectations from
both individual employees and the team. In addition, ap-
propriate management support will be sought for the en-
vironmental component to be incorporated into the office
workspace and for health coaching elements to be con-
ducted during work time. Managers will be asked to pro-
vide written informed consent and express unreservedcommitment to having their employees participate in the
study. Consenting sites will be randomised to either the
intervention or control arms of the trial.
Recruitment of participants
An initial information session (20–30 minutes) will be
delivered by research staff to employees of consenting
sites. At this session, employees will be given detailed in-
formation on the study and the required commitment.
Following this session, an expression-of-interest form
will be distributed for return either to their worksite
team leader or directly to the research staff. Employees
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for eligibility via a telephone-administered interview.
During the telephone interview, the research coordinator
will explain the study, assess eligibility, and solicit verbal
willingness to participate. If the employee is eligible and
interested, they will then be emailed the participant in-
formation and consent form. Participants will be consid-
ered formally enrolled upon return of the signed consent
form prior to commencement of study assessments.
Randomisation
Randomisation to either the intervention or control arms
of the trial will be at the level of the study site. Simple
cluster randomisation will be achieved by generating a
randomisation plan for up to 24 clusters/worksites in one
block (www.randomization.com). Participating sites will
subsequently be randomly matched against the random-
isation plan using a list randomiser (www.random.org).
This method allows study staff to implement the study
intervention and control protocols in an order consistent
with logistical capacity. Study sites will be enrolled and
then randomized until the required number of clusters
and sample size is reached.
Control – usual practice
Participants within the control sites will be advised that
the aims of the study are to examine the consistency of
patterns of physical activity and sedentary time in office
workers, and how these may be associated with cardio-
metabolic and anthropometric markers. The control
group will receive the same assessments at the three
time points as the intervention group.
Intervention
Theoretical basis & intervention development
Stand Up Victoria is a multicomponent intervention
comprising organisational, environmental and individual
elements. Extensive formative research was used to
guide intervention development and is described in a
separate paper (Manuscript Submitted). In brief, this in-
cluded testing of each intervention element on small
samples of office workers, including an evaluation of the
effectiveness and acceptability of the sit-stand worksta-
tions [17]. The formative research culminated with a
two-group (intervention versus control) pilot study
(Stand Up Comcare) in which all intervention elements
were combined and evaluated in an abbreviated version
of the intervention [20]. The intervention is based on
Social Cognitive Theory, with emphasis on the con-
structs of self-efficacy, outcome expectancies and socio-
structural factors [48]. An intervention taxonomy of be-
haviour change strategies [49] guided the translation of
the theoretical components into intervention strategies
(described below). The intervention will be deliveredover three months, with this duration being consistent
with the median length of interventions included in a re-
cent meta-analysis of workplace physical activity inter-
vention trials [50].
Intervention messages
The intervention comprises three key strategic messages:
“Stand Up, Sit Less, Move More”. ‘Stand Up’ is a prompt
to break-up prolonged bouts of sitting. The aim is to re-
duce musculoskeletal symptoms and to promote benefi-
cial physiologic changes associated with regular, frequent
muscle activation [27,51]. Building on both OHS guide-
lines [25,41,42], as well as recent experimental evidence
[27,51], the recommendation is to interrupt sitting at
least every 30 minutes with postural change. ‘Sit Less’
communicates a reduction in overall sitting time by sub-
stituting some sitting with either standing or moving,
aiming for an approximately equal sit to stand ratio over
the course of the day. Here, the workstation is promoted
as a primary means for reducing overall sitting time. Fi-
nally, the principle of ‘Move More’ is to increase phys-
ical activity throughout the working day; primarily
through opportunistic, incidental activity.
Intervention procedures
Organisational elements The organisational level of
the intervention will include three key elements: a senior
management consultation; a representatives’ consultation
workshop; and, a participant information and brain-
storming session (see Figure 1). Visible ongoing organ-
isational support will be demonstrated through the
distribution of tailored emails from management.
Senior management consultation
In order to establish the study, senior research staff met
with senior DHS management to describe the back-
ground and rationale of the study and the study timeline,
and obtain consent for the trial. This involved obtaining
approval for intervention units to have physical work en-
vironment modifications (detailed below) as well as
other intervention activities at the organisational and in-
dividual levels. Current organisational processes and
structures important to study implementation were
considered, including potentially eligible worksites.
Strategies to encourage employee participation were
discussed and relevant OHS policies and resources
identified (e.g. policies relating to workplace activity).
The organisation has dedicated a staff member as the
research liaison person (at 0.4 FTE for the duration
of study; paid by the organisation), aiding in recruit-
ment of work teams into the trial, as well as organising
logistics for all assessments and work environment
modifications.
Dunstan et al. BMC Public Health 2013, 13:1057 Page 6 of 14
http://www.biomedcentral.com/1471-2458/13/1057Representatives consultation workshop
Following the senior management consultation, a work-
shop (approximately 4 hours), facilitated by senior research
staff, will be conducted with DHS staff representatives.
Representatives will include employees from the respective
levels of staff (including general staff and senior and middle
managers) as well as other stakeholders including OHS
personnel, workplace safety advisors, and corporate ergon-
omists. During the workshop, the research staff will pro-
vide information on the background and rationale of the
study, the target behaviour, and the key intervention mes-
sages. The representatives will then brainstorm feasible
strategies to Stand Up, Sit Less, Move More within DHS.
Team champions will be identified, and their role described
(further details below).
Participant information and brainstorming session
Following baseline assessment, an information and
brainstorming session (approximately 30–45 minutes)
will be delivered by research staff to participants at each
study worksite. Each session will: (1) outline recent re-
search findings on the health consequences of excessive
sitting using standard materials developed by the re-
search team; (2) provide summary feedback of device-
measured sitting and activity time generated from the
group’s baseline assessment; and, (3) include a brain-
storming component. Strategies identified in the repre-
sentatives’ consultation workshop will be discussed, with
further brainstorming from all staff to identify and agree
upon strategies that are specifically suitable for their local
worksite. As part of this brainstorming session, the Heart
Foundation of Australia consumer information sheet “Sit-
ting less for adults” containing tips on how to reduce sit-
ting time in the workplace [52] will be used to facilitate
discussion and to prompt further ideas. An email sum-
mary (sent by the research team) of the information and
consultation session will be sent to all participants. This
email will include an electronic information booklet
(Additional file 1: Figure S1) containing information on
the background and rationale for the study; general guide-
lines on achieving optimal workplace activity; specific be-
haviour change strategies related to the key intervention
messages; and, general information about the study proce-
dures and timeline.
Ongoing organisational support
Team champions (typically the worksite team leader)
will be encouraged to actively promote participation in
the study and the implementation of the organisational-
level strategies identified in the brainstorming sessions.
Team champions will also facilitate communication be-
tween participants and research staff and have the re-
sponsibility for sending the tailored management emails.
The purpose of the management emails is to foster asense of management support for the key intervention
messages. Six email templates, featuring themes of the
detrimental effects of prolonged sitting and the benefits
of standing and moving more, will be provided to team
champions at weeks 2, 4, 6, 8, 10 and 12 for them to
send to participants within their team (example provided
in Additional file 2: Figure S2). Notably, the second
management email (week 4) also includes a list of strat-
egies to reduce sitting time outside the workplace, which
parallels the purpose and content of the week 4 tele-
phone support call (see below). Team champions will be
encouraged to personalise the templates by highlighting
particularly successful strategies to Stand Up, Sit Less
and Move More within their worksite. The research
team will be blind copied on the emails to inform evalu-
ation of intervention fidelity.
Environmental element
A dual-screen sit-stand workstation (Ergotron WorkFit-S;
www.ergotron.com), including worksurface accessory
(a flat surface positioned above the keyboard), will be
provided to all intervention participants for the duration
of the study (12 months). The workstation allows the
participant to easily and quietly alternate their working
posture between sitting and standing. It uses minimal
desk space, and the keyboard and monitor can move in-
dependently to ensure that the appropriate ergonomic
posture is maintained. Participants will receive written
instructions and tips on the correct ergonomic posture
for both sitting and standing, as recommended by the
product manufacturer (www.ergotron.com/tabid/305/
language/en-AU/Default.aspx; Additional file 3: Figure S3).
Adhesive stickers will be applied to the workstations by
research staff to indicate the recommended configur-
ation – i.e. keyboard and screen position – tailored for
each individual for both sitting and standing postures.
Individual elements
Individual-level support for behaviour change delivered
to each participant will consist of a face-to-face health
coaching session (1–3 days following workstation instal-
lation; approximately 30 minutes) and four telephone
calls at weeks 2, 4, 8 and 12 (7–10 mins each) following
the individual session. Where feasible, the same health
coach will remain the point of contact for each par-
ticipant throughout the study to facilitate rapport. All
health coaches will have at least a bachelor’s level train-
ing in psychology or a related discipline and will receive
training in motivational interviewing techniques adapted
for study purposes [53]. Detailed intervention scripts will
be used for coach training with accompanying checklists
used during intervention delivery to maintain interven-
tion fidelity. Further, health coaches will debrief regularly
(monthly for the first few months and then quarterly)
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element of the intervention (EE, GH) during the active
intervention phases.
Individual coaching
The coaching will be used to: explain the Stand Up, Sit
Less, Move More intervention targets; to feedback partic-
ipant’s assessment results on the extent to which the
participant is meeting these targets (derived from the
activity monitors worn at baseline; Additional file 4:
Figure S4); and, to identify specific goals and behaviour
change strategies relating to each of these key interven-
tion messages. The strategies identified in the brain-
storming session will be shown to participants who will
be encouraged to develop their own strategies as appro-
priate. A laminated workstation tracker (Additional file 5:
Figure S5) will be provided for participants to record their
goals and strategies. They will be encouraged to place this
within eyesight of their workstation for self-monitoring
purposes. Health coaches will record these goals on their
own intervention worksheet, which will be referred to
during the telephone calls. During this face-to-face ses-
sion, participants will also receive instruction on the ergo-
nomic setup and appropriate use of the workstation. This
will include specific instructions to “listen to their body”,
and to regularly change posture (i.e. to neither sit or stand
for too long). Following the consultation, a personalised
email summary of the session will be sent to participants
from the health coach.
Telephone calls
Four telephone calls will be used to support goal attain-
ment. They will involve assessment of participant pro-
gress toward previously set goals, problem-solving as
necessary, and adjustment/progression of goals and re-
lated behaviour change strategies. The second phone call
(week 4) will also address strategies to reduce sitting
time outside the workplace. Health coaches will record
notes about individual’s progress and amended goals,
while participants will be encouraged to update their
workstation tracker accordingly. Call attempts, comple-
tions, and duration will be tracked, and a call content
checklist completed after each call to inform an evalu-
ation of intervention fidelity.
Data collection
Assessments will be undertaken at baseline, 3-, and 12-
months in designated testing rooms at the respective
worksites by trained project staff. Participants will re-
ceive verbal and written requests (with confirmation of
compliance at data collection time) to refrain from any
MVPA, alcohol, and caffeine in the 24 hours preceding
each assessment, and to fast for at least eight hours. This
is to minimise any potential confounding with respect tobiomarker outcomes. A fasting blood sample will be col-
lected on-site and the sample analysed by an accredited
pathology laboratory. Sitting, standing, and moving time
outcomes will be collected via activity monitors in the
seven days following the onsite assessment. Participants
will receive full instruction on the use of the activity
monitors and the accompanying daily log. The devices
and the daily logs will be collected by research staff at
the end of each seven day period. A self-administered
questionnaire will be completed online using the Lime-
Service (www.limeservice.com) survey creation and host-
ing platform. Participants will access the survey using
unique tokens contained within an email invitation. This
ensures both exclusivity and confidentiality. In addition,
descriptive information relating to the respective inter-
vention worksites (e.g.,: office layout and stair availability
will be obtained by research staff. Full details of the mea-
sures are provided below and in Table 1.
Outcomes
Sitting, standing and moving time
Sitting, standing, and moving time will be objectively
measured via an activPAL3 activity monitor (PAL Tech-
nologies Limited, Glasgow, UK; default settings). This
monitor continuously records the precise beginning and
ending of each bout of sitting or lying (here termed sit-
ting), standing, and stepping at a variety of speeds, and
the estimated MET-hours expended during those bouts.
Previous studies have shown this device to be valid, reli-
able and responsive [54-57]. Waterproofing of the device
will be achieved by first inserting it into a nitrile finger
cote and then wrapping the device in waterproof Opsite
Flexifix(™) (Smith & Nephew).Thereafter, the activPAL3
will be secured to the anterior mid-line of the right
thigh, about a third of the way down from the hip, using
hypoallergenic adhesive material (Hypafix®, BSN med-
ical). Additional hypoallergenic patches will be given to
participants for the adhesive materials to be changed as
required. Participants will be requested to wear the
activPAL3 activity monitor for 24 hours per day, for
seven consecutive days at each assessment period (base-
line, 3-, and 12-months). At each assessment, partici-
pants will also concurrently wear the tri-axial GT3X +
Actigraph activity monitor (ActiGraph, Pensacola, Florida).
Participants will be asked to wear this activity monitor
during waking hours only (except for water-based activ-
ities) for the seven-day assessment period. The accelerom-
eter is positioned over the right hip via an elastic belt. The
raw accelerometer data will be collected at 30Hz.
Daily logs (self-completed) will be used to record wake
and sleep times, work hours (defined as time spent at the
primary DHS study worksite), and any device removal
greater than 15 minutes. Periods of work time spent not
at the primary worksite (i.e. working from home) will also
Table 1 Summary of measures used in the Stand Up
Victoria office workplace intervention
Behavioural Objectively measured physical activity and
sitting time
Objective & self-report activPAL3
● Workplace sitting time (primary outcome)
● Prolonged (>= 30 mins) workplace sitting time
● Workplace standing time
● Workplace moving time (stepping time, no. steps)
● Number of sit-stand transitions at workplace
● Non-workplace sitting, standing, moving time
Actigraph GT3X+
● Average daily MVPA
● Average daily light physical activity
Self-report measures
● % sitting, standing, walking and physically
demanding tasks at work
● Recent work attendance (days/week;
hours/week)
● Non-workplace sitting time; TV/video
viewing time
● Diet (fat intake; fibre intake)
● Smoking status
Anthropometric
Objectively measured
● Height (baseline only)
● Weight
● BMI (kg/m2)
● Waist circumference
● Hip circumference
● Waist-Hip ratio
● Body composition (% and kg fat and
fat-free mass)
Cardio-metabolic
Objectively measured
● Fasting blood glucose
● Fasting insulin
● Cholesterol (total, HDL, LDL)
● Triglycerides
● Blood pressure
Socio-demographic
Self-report
All baseline only
● Age
● Gender
● Race/ethnicity
● Marital status
● Education
Health status
Self-report
● History of diabetes & hyperlipidaemia
(baseline only)
● Musculoskeletal health
● Eye strain
● Stress-related symptoms (fatigue, headaches,
digestive problems, sleep quality)
Table 1 Summary of measures used in the Stand Up
Victoria office workplace intervention (Continued)
Work
Self-report, internal DHS
measure, and employee
records
● Employment status (baseline only) including
length of tenure; job classification; full-time
equivalent (FTE) level
● Secondary employment status (including FTE)
● Productivity
● Presenteeism/absenteeism
● Work performance
Psychosocial-
Environmental
Self-report and
objectively measured
● Perceptions of the work environment
● Desk/workstation utilisation
● Frequency and duration of working with
colleagues as well as perceived adequacy
of space(s) for such interactions.
● Quality of life
● Acceptability of workstations (intervention
group only)
● Preference for sitting and standing in the
workplace
● Knowledge
● Barrier self efficacy
Perceived behavioural control
● Perceived organisational social norms
● Use of self-regulation strategies
● Use of intervention-specific strategies
● Descriptive office audit
Cost-effectiveness
Self-report
● Health-related quality of life
● Health care utilisation
● Cost to deliver intervention
● Adverse events (intervention group only;
3 and 12 months only)
All measurements completed at baseline, 3- and 12-months except where noted.
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Cary, NC) program, utilising both the activity monitor
and log data, will be used to generate sitting, standing,
and moving outcomes at work and overall, with the pri-
mary outcome being sitting time at work (measured by
activPAL3). Consistent with the intervention message,
prolonged sitting is defined as time accrued in sitting
bouts at least 30 minutes in length. The number of
transitions between sitting and standing will also be
measured. The GT3X + activity monitor will be used to
differentiate time spent in light-intensity physical activity
and MVPA.
Anthropometry: height, weight and body composition
Waist circumference will be measured (nearest 0.1 cm)
with a non-expandable tape at the midpoint between the
lowest rib and the iliac crest. Hip circumference (nearest
0.1 cm) will be taken as the maximum circumference in
the horizontal plane, measured over the buttocks. For
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taken in duplicate with a third measurement taken if the
first two differ by ≥ 1 cm. Fat mass, fat-free mass and
percent body fat will be measured using foot-to-foot bio-
electrical impedance analysis (BIA) scales (Model TISC-
330S, Tanita Inc., Tokyo, Japan) in the fasted and voided
state. Bioimpedance analysis will not be conducted on
participants with a pacemaker. Weight will concurrently
be measured using the same BIA scales without shoes
and wearing light garments to the nearest 0.1 kg.
Standing height will be measured to the nearest
0.1 cm, without shoes and the individual’s eyes looking
straight ahead (Frankfort plane), using a portable stadi-
ometer. Height will be measured in duplicate with a
third measurement taken if the difference is ≥ 0.5 cm.
Body mass-index (BMI; kg/m2) will be calculated using
the average height and weight obtained from the above
measures.
Cardio-metabolic markers
Fasting blood samples will be collected on-site in the
morning by a trained phlebotomist for the analyses of glu-
cose, lipids (triglycerides, high density lipoprotein [HDL]
cholesterol and low density lipoprotein [LDL] cholesterol)
and insulin. Samples will be sent immediately to an accre-
dited testing laboratory for analysis (Melbourne Path-
ology). Fasting plasma glucose will be measured by
spectrophotometric-hexokinase method. Fasting total
cholesterol, HDL- cholesterol and triglycerides will be
measured via standard enzymatic-colorimetric methods.
LDL-cholesterol will be estimated using the Friedewald
equation [51]. Insulin will be measured by electrochemilu-
minescence immunoassay (ECLIA). All blood chemistry
analytes will be measured using Roche/Hitachi cobas® sys-
tem analysers (Tokyo, Japan). Blood pressure will be mea-
sured via a digital blood pressure monitor (OMRON
HEM-907; Omron Healthcare, Japan) using the right arm
and an appropriately sized cuff. Participants will rest in
the seated position for 15 minutes prior to having a mini-
mum of two measurements taken at one-minute intervals.
A third measurement will be taken if the systolic differs
by >10 mmHg or the diastolic by >6 mmHg.
Survey measures
Socio-demographic characteristics Based on questions
used in the Australian Diabetes, Obesity and Lifestyle
(AusDiab) study [58], information relating to age, gen-
der, ethnicity, marital status, and education will be ob-
tained (baseline assessment only).
Physical health history data Musculoskeletal health
will be measured using the 27-item Nordic Musculoskel-
etal Questionnaire, modified to refer to the last seven
days and the last three months (instead of 12 months)[59]. This questionnaire includes items on ‘trouble’ in
numerous body parts as well as the capacity to perform
normal activities in the presence of any ‘troubles’, and
has been shown to be repeatable and sensitive to change
[60]. Eye-strain will be assessed with three items used in
a previous ergonomics intervention study, where it was
shown to have high internal consistency [61]. A check-
list, adapted from previous work that has demonstrated
good internal consistency [62], will assess physical health
symptoms commonly associated with stress such as fa-
tigue, headaches, digestive problems and sleep quality.
Current smoking status (including at work) and history
of diabetes and hyperlipidaemia will also be collected.
Self-reported physical activity and sitting time Partic-
ipants will be asked to estimate the total time spent
watching TV/videos during the week and on weekends;
average daily sitting time during the week and on week-
ends; and the proportion of sitting, standing, walking
and physically demanding tasks during a typical work
day in the previous seven days [63,64].
Work outcomes Productivity, presenteeism, and absen-
teeism will be obtained for each assessment period using
internal DHS measures and validated questionnaires
[65-67]. The Health and Work Questionnaire (HWQ)
has six sub-scales (productivity, concentration/focus,
supervisor relations, non-work satisfaction, impatience/
irritability), with internal consistency scores ranging
from alpha = 0.72 to 0.96 [65]. In addition, a total HWQ
score will be calculated (alpha = 0.81) [65]. Self-reported
work performance will be assessed on a 9-item, 10-point
scale [66]. Performance items include amount and qual-
ity of work accomplished, meeting deadlines, frequency
of errors, taking responsibility, creativity, getting along
with others, dependability and overall performance [66].
Presenteeism and absenteeism will be assessed using the
proprietary Work Limitations Questionnaire (WLQ),
which examines the frequency of difficulty to perform
specific job tasks [67].
Work history and environment Questions will assess
perceptions of the work environment and current work
patterns including: length of tenure; job classification;
FTE level; desk/workstation utilisation; environmental
satisfaction; and, frequency and duration of working
with colleagues as well as perceived adequacy of space(s)
for such interactions. Previously validated instruments
[35,66,68] and items developed specifically for this study
(Additional file 6: Figure S6) will be used.
Dietary intake will be measured using the 20-item Fat
& Fibre Behaviour Index which asked about eating
habits over the previous month. This questionnaire has
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and has been shown to be sensitive to change [69].
Mediators Potential mediators of change have been
conceptualised under the three levels of intervention (or-
ganisational, environmental, individual). All mediators
will be assessed in both groups at all assessments via the
on-line questionnaire. The organisational mediator to be
assessed will be the site-specific team champion’s atti-
tudes and knowledge (scales described below). At the
environmental level, participants will be asked to report
the frequency of use of their workstation in the past
month on a 5-point Likert scale (from ‘never’ to ‘very
often’). Individual-level mediators will include the fol-
lowing theoretical constructs: preference for sitting and
standing at work; knowledge; barrier self efficacy; per-
ceived behavioural control; perceived organisational so-
cial norms; as well as frequency of use of self-regulation
strategies and other individual-level intervention strat-
egies. There are no existing measures for these
individual-level constructs in relation to workplace sit-
ting; therefore, where possible, we have adapted scales
from the more developed physical activity literature or
otherwise a study-specific scale was created. All of the
scales were pilot tested in our previous workplace sitting
intervention [20] and the psychometric properties (in-
ternal consistency and test-retest reliability) of these
scales can be found in Additional file 7: Table S1. Prefer-
ence will be measured across two items on a 5-point
scale indicating the proportion of work time participants
preferred to be sitting or standing (ranging from ‘none
of the time’ to ‘80-100% of time’). Knowledge of key
intervention messages will be assessed across five items
(e.g., “Sitting for most of the time at work is bad for my
health”); on a 5-point Likert scale (‘strongly disagree to
‘strongly agree’). The barrier self efficacy scale has been
adapted from an existing scale [70] and will assess nine
items referring to specific barriers to reducing workplace
sitting (e.g., confidence to ‘stand up during meetings at
work, even though no one else was’), which will be
assessed on a 5-point Likert scale (‘not at all confident’
to ‘very confident’). Perceived behavioural control will be
examined across five items (e.g., ‘It is my choice whether
I stand up or sit during a meeting with colleagues at
work’) on a 5-point Likert scale (‘strongly disagree to
‘strongly agree’). Organisational social norms will be
assessed in eight items (e.g., ‘My workplace is committed
to supporting staff choices to stand or move more at
work’) on a 5-point Likert scale (‘strongly disagree to
‘strongly agree’). Self-regulation will be examined across
10 items on a 5-point Likert scale (‘never’ to ‘very
often’), adapted from an existing scale for physical activ-
ity [71] and will include self-regulation strategies tar-
geted in the intervention (e.g., “recorded my sitting orstanding at work in a written record”). In addition, fre-
quency of use of intervention-specific strategies is also
assessed across nine items on a 5-point Likert scale
(‘never’ to ‘very often’). The complete set of questions is
provided in Additional file 8: Figure S7.
Moderators These will be assessed at baseline in both
study groups. Potential moderators will be grouped as:
demographic (e.g., age, gender, BMI, health status);
work-related characteristics (e.g., position, hours worked
per week, main work tasks); office environment charac-
teristics assessed as part of the baseline workplace de-
scriptive audit (e.g., office layout); and behavioural
characteristics (e.g., MVPA, sitting outside work hours).
Adverse events The adverse events that the participant
attributes as “study-related” will be collected at each
follow-up assessment in the intervention group only.
Health care utilisations (number of visits to GPs and al-
lied health care professionals) pertaining to the adverse
event (s) will also be measured as part of the economic
evaluation (Additional file 9: Figure S8).
Quality of life will be measured using the validated
Australian Quality of Life Survey (AQoL-8D) which con-
sists of eight separately scored dimensions (Independent
Living, Happiness, Mental Health, Coping, Relationships,
Self Worth, Pain, Senses) totalling 35 items [72].
Qualitative interviews
At the end of the intervention (post 12 months), inter-
views will be undertaken with a sample of intervention
participants, all intervention team leaders, and senior
DHS management. The sample of intervention partici-
pants (a minimum of two from each intervention work-
site) will be randomly selected from those who “opt-in”
for this element on the final assessment questionnaire.
The interviews will be semi-structured and delivered
face-to-face by one research staff member. The inter-
views with participants and team leaders will include
evaluation of the different intervention elements and ad-
herence to the study site strategies identified and agreed
upon within the group information session, as well as
perceived organisational support for the key messages.
The interviews with the senior management will also be
semi-structured and delivered face-to-face, with the ob-
jectives being to canvass perspectives on the implemen-
tation of the intervention and next steps relating to the
broader translation/dissemination of similar initiatives
within the organisation.
Economic evaluation
An economic evaluation will be undertaken alongside
the trial to determine whether the intervention
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trol group (current practice). It will address issues of
both technical efficiency (‘how to do it’) through assess-
ment of key design features of the intervention and the
associated cost drivers, and allocative efficiency (‘what to
do’) through the modelling of longer term consequences
and cost offsets. In addition to a ‘trial-based evaluation’
(costs and outcomes exactly as per the trial), a ‘modelled
economic evaluation’ will also be undertaken, which ex-
tends the target population, time horizon and decision
context.
Feedback of study outcomes
Individual feedback on baseline patterns of sitting,
standing and moving time both at the workplace and
across all waking hours will be received by intervention
participants as part of their one-on-one consultation to
facilitate goal setting (Additional file 4: Figure S4). At
the completion of both the 3- and 12-month assess-
ments, all participants will receive individual feedback
letters containing details of their average sitting, stand-
ing, and moving time (both at the workplace and overall)
and their anthropometric and cardio-metabolic out-
comes, including sex- and gender-specific reference/
desirable ranges where applicable. This feedback will
also include details of change from the previous assess-
ment(s). Participants will be encouraged to consult their
doctor to discuss any cardio-metabolic results outside
the desirable range. To ensure participant safety, medical
results requiring urgent attention will be communicated
to the participant as soon as the health concern is
identified.
Sample size
Minimum differences of interest (MDI) for activity out-
comes were 45 minutes of sitting, standing, prolonged
sitting, and light activity, and 15 minutes of stepping
and MVPA. Based on our study design, we expected an
average of 20 participants/cluster, with strong clustering
(ICC = 0.1; Design effect = 2.9) for activity (heavily influ-
enced by workplace) and weak clustering (ICC = 0.01;
Design Effect = 1.19) for the other outcomes (weakly in-
fluenced by workplace) with overall attrition of 30%.
Standard deviations and pre-post correlations were as-
sumed based on the earlier pilot [20].
Based on these assumptions, the sample size required
to detect the MDI (45 min) for the primary outcome
(workplace sitting, assumed SD = 70, pre-post correl-
ation = 0.4) is 160 per group, spread across 8 clusters
each. This sample size provides adequate power (≥90%)
to detect minimum differences of interest on secondary
workplace and overall activity outcomes, with assumed
SDs and pre-post correlations (r) of 70–75 mins (r = 0.4)
for sitting, standing and prolonged sitting; 20–35 minutes(r = 0.7) for stepping and MVPA; and, 60 minutes (r =
0.7) for light activity.
For the other secondary outcomes, minimum detect-
able differences (MDD) with 80-90% power were: 1.7-
1.8 kg weight, 1.3-1.5 kg lean body mass and fat mass,
1.5-1.7 cm waist circumference, 5–6 mmHg systolic
blood pressure, 4 mmHg diastolic blood pressure, 11–13
pmol insulin, 0.28-0.33 mmol/L glucose, 0.24-0.25 /0.19-
0.22 / 0.10-0.11 mmol/L total / LDL- / HDL- choles-
terol, 0.12-0.14 mmol/L log triglycerides, 0.3-0.4 units
work performance, 0.3-0.4 units eyestrain, 0.6-0.7 units
fatigue. Based on these MDDs, power would be adequate
to detect effect sizes of the magnitude observed in the
pilot study [20] for glucose (0.3 mmol/L), insulin (15.7
pmol) log triglycerides (0.19 mmol/L) and diastolic
blood pressure (4.0 mmHg) only.
Statistical analyses
In accordance with the study aims, statistical analyses
will be conducted to determine whether the intervention
group differs from the control group in changes over
time in primary and secondary outcomes. Statistical sig-
nificance will be set at the conventional 5% level (two-
tailed). Consistent with the cluster-randomised design,
and in order to examine both workplace-level and
individual-level variation, Linear Mixed Models will be
used (SAS version 9.3 or STATA version 12). These
models will use random intercepts for workplace and in-
dividuals (to account for clustering within workplaces
and repeated measures) and will adjust for baseline
values and potential confounders. Appropriate distribu-
tions (e.g., normal, gamma, binomial) and links (e.g.,
identity, log) will be used depending on the distribution
of the data. Potential confounders will initially be identi-
fied a priori based on the findings of our preceding epi-
demiological studies and the relevant research literature,
and will be controlled via statistical adjustment as rele-
vant to each specific outcome should they display associ-
ation with the outcome (significant at p < 0.2). Analyses
will follow intention-to-treat principles. Assumptions
will be tested regarding missing data, randomisation,
and contamination (an important consideration given
that the study sites are all within the one organisation).
Contamination will be assessed by tracking individuals
within study sites (i.e. transfers to a study site of the
same allocation, no allocation or opposite allocation)
and by assessing, at the end of the program, self-
reported use of specific intervention strategies to reduce
prolonged sitting.
Moderation and mediation
Moderator analysis will examine whether intervention
effects differ across individual (e.g. age, gender) and
workplace characteristics (e.g. office layout). Moderation
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interaction terms to test moderation. Theoretically-
driven constructs and mechanisms (described above) will
be examined as possible mediators of the intervention
effects, using established methods appropriate to a clus-
ter design as some proposed mediators will vary at the
individual-level (e.g. preferences) whilst others will only
vary at the organisational level (e.g. manager’s attitudes
and knowledge) [73].
Incremental cost-effectiveness analyses
Detailed pathway analysis will be used to specify all ac-
tivities undertaken as part of the intervention in order to
measure costs of associated resource use (e.g. provision
and installation of workstations, information sessions,
telephone check-ups, weekly emails, adverse events).
Unit costs will be drawn from best available sources for
the 2012 reference year. In addition to incremental costs
of the intervention (measured against the comparator),
incremental cost offsets attributable to disease preven-
tion in the long-term will be reported. The cost data will
be combined with the behavioural and biomarker out-
comes to produce a range of incremental cost effective-
ness ratios (ICERs), across both primary and secondary
outcomes, including cost per unit reduction in sedentary
time and cost per quality-adjusted life year (QALY)
gained (based on AQoL-8D [72]). The modelled evalu-
ation will use a Markov approach to estimate the health
and cost impacts of changes in sedentary status over the
lifetime of participants. Standard discounting will be ap-
plied to both costs and outcomes. Simulation-modelling
using the @RISK software package will be employed to
calculate 95% uncertainty intervals (median, 2.5 and 97.5
percentiles) around the epidemiological probabilities and
cost estimates.
Discussion
Substantial epidemiological evidence has provided the
rationale for identifying prolonged workplace sitting
time as an emerging public health concern. The critical
next step in informing public health policy and practice
is the conduct of randomised controlled workplace
intervention trials. Such trials are essential for determin-
ing the feasibility, effectiveness and sustainability of re-
ducing workplace sitting time, as well as the impact on
biomarkers of chronic disease risk. The Stand Up
Victoria trial is unique, in that it takes a whole-of-
organisation approach to reducing prolonged workplace
sitting, evaluates the impact of the intervention on a
broad range of health (including biomarkers of cardio-
vascular health) and work-related outcomes, and incor-
porates objective measures of workplace sitting time and
physical activity – as distinct from relying on self-report
measures. It will also measure the cost effectiveness ofthe intervention – a critical influence in deciding future
uptake within workplaces. Similarly, identification of the
moderators of the intervention effect on workplace sit-
ting will lead to improved understanding of which
workers may be most suited to this type of intervention.
These analyses may help inform targeted delivery of the
intervention to specific sub-groups of workers and the
appropriate adaptation of the intervention for other sub-
groups for which it was less successful. These methodo-
logical strengths are important for advancing the science
of settings-based approaches to sedentary behaviour
change, as well as building the evidence base for the
translation of this work into population-health and
workplace-health practice.
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